why is compound semaglutide not fda approved Proposes Ban on Bulk Compounding for Semaglutide, Tirzepatide, and Liraglutide FDA warns against using compounded

Budget constraints matter

The pharmaceutical industry's evolution in obesity therapeutics has progressed from single-target approaches (pure GLP-1 agonists like semaglutide) to dual agonists (GLP-1/GIP like tirzepatide), and now to triple agonists like retatrutide that attempt to orchestrate an even more comprehensive metabolic remodeling by simultaneously modulating multiple complementary pathways

However, these medications may be covered under Medicare for type 2 diabetes, cardiovascular risk reduction (Wegovy), or obstructive sleep apnea (Zepbound)

His blood work was perfect and testosterone levels were optimal